Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 128

1.

A population-based study showing better renal prognosis for proteinase 3 antineutrophil cytoplasmic antibody (ANCA)-associated nephritis versus myeloperoxidase ANCA-associated nephritis.

Mohammad AJ, Segelmark M.

J Rheumatol. 2014 Jul;41(7):1366-73. doi: 10.3899/jrheum.131038. Epub 2014 Jun 1.

PMID:
24882836
[PubMed - indexed for MEDLINE]
2.

Prolonged infections associated with antineutrophil cytoplasmic antibodies specific to proteinase 3 and myeloperoxidase: diagnostic and therapeutic challenge.

Bonaci-Nikolic B, Andrejevic S, Pavlovic M, Dimcic Z, Ivanovic B, Nikolic M.

Clin Rheumatol. 2010 Aug;29(8):893-904. doi: 10.1007/s10067-010-1424-4. Epub 2010 Mar 20.

PMID:
20306213
[PubMed - indexed for MEDLINE]
3.

Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis.

Lionaki S, Blyth ER, Hogan SL, Hu Y, Senior BA, Jennette CE, Nachman PH, Jennette JC, Falk RJ.

Arthritis Rheum. 2012 Oct;64(10):3452-62. doi: 10.1002/art.34562.

PMID:
23023777
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients.

Geffriaud-Ricouard C, Noël LH, Chauveau D, Houhou S, Grünfeld JP, Lesavre P.

Clin Nephrol. 1993 Mar;39(3):125-36.

PMID:
7681736
[PubMed - indexed for MEDLINE]
5.

Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.

Vizjak A, Rott T, Koselj-Kajtna M, Rozman B, Kaplan-Pavlovcic S, Ferluga D.

Am J Kidney Dis. 2003 Mar;41(3):539-49.

PMID:
12612976
[PubMed - indexed for MEDLINE]
6.

A novel enzyme-linked immunosorbent assay using a mixture of human native and recombinant proteinase-3 significantly improves the diagnostic potential for antineutrophil cytoplasmic antibody-associated vasculitis.

Damoiseaux J, Dähnrich C, Rosemann A, Probst C, Komorowski L, Stegeman CA, Egerer K, Hiepe F, van Paassen P, Stöcker W, Schlumberger W, Tervaert JW.

Ann Rheum Dis. 2009 Feb;68(2):228-33. doi: 10.1136/ard.2007.086579. Epub 2008 Mar 28.

PMID:
18375539
[PubMed - indexed for MEDLINE]
7.

Clinical and pathological manifestations of patients with antineutrophil cytoplasmic autoantibodies directed against proteinase 3 or myeloperoxidase.

Zhang X, Dong Y, Zeng X, Li Y, Tang F.

Chin Med Sci J. 2002 Mar;17(1):32-5.

PMID:
12894882
[PubMed - indexed for MEDLINE]
8.
9.

EUROPLUS ANCA BIOCHIP mosaic: PR3 and MPO antigen microdots improve the laboratory diagnostics of ANCA-associated vasculitis.

Damoiseaux J, Steller U, Buschtez M, Vaessen M, Rosemann A, van Paassen P, Stöcker W, Fechner K, Tervaert JW.

J Immunol Methods. 2009 Aug 31;348(1-2):67-73. doi: 10.1016/j.jim.2009.07.001. Epub 2009 Jul 14.

PMID:
19615371
[PubMed - indexed for MEDLINE]
10.

Propylthiouracil-associated antineutrophil cytoplasmic autoantibody-positive vasculitis: retrospective study of 19 cases.

Chen YX, Yu HJ, Ni LY, Zhang W, Xu YW, Ren H, Chen XN, Wang XL, Li X, Pan XX, Wang WM, Chen N.

J Rheumatol. 2007 Dec;34(12):2451-6. Epub 2007 Nov 1.

PMID:
17985400
[PubMed - indexed for MEDLINE]
11.

Proteinase-3 antineutrophil cytoplasm antibody positivity in patients without primary systemic vasculitis.

McAdoo SP, Hall A, Levy J, Salama AD, Pusey CD.

J Clin Rheumatol. 2012 Oct;18(7):336-40. doi: 10.1097/RHU.0b013e31826d2005.

PMID:
23047533
[PubMed - indexed for MEDLINE]
12.

ANCA-associated vasculitis with renal involvement: an outcome analysis.

Weidner S, Geuss S, Hafezi-Rachti S, Wonka A, Rupprecht HD.

Nephrol Dial Transplant. 2004 Jun;19(6):1403-11. Epub 2004 Apr 6.

PMID:
15069175
[PubMed - indexed for MEDLINE]
Free Article
13.

Analytical and diagnostic accuracy of the EliA automated enzyme fluoroimmunoassay for antineutrophil cytoplasmic autoantibody detection.

Villalta D, Tonutti E, Tampoia M, Bizzaro N, Papisch W, Tozzoli R, Stella S.

Clin Chem Lab Med. 2004;42(10):1161-7.

PMID:
15552276
[PubMed - indexed for MEDLINE]
14.

ANCA-associated vasculitis: diagnostic and therapeutic strategy.

Ozaki S.

Allergol Int. 2007 Jun;56(2):87-96. Epub 2007 May 1. Review.

PMID:
17460438
[PubMed - indexed for MEDLINE]
15.
16.

Incidence of PR3- and MPO-ANCA autoantibody specificity changes in ANCA-associated vasculitis.

Holding S, Fisher VJ, Abuzakouk M.

Ann Clin Biochem. 2015 Mar;52(Pt 2):297-301. doi: 10.1177/0004563214533668. Epub 2014 Apr 10.

PMID:
24723621
[PubMed - in process]
17.

Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis.

Csernok E, Lamprecht P, Gross WL.

Curr Opin Rheumatol. 2010 Jan;22(1):43-8. doi: 10.1097/BOR.0b013e3283323538. Review.

PMID:
19770659
[PubMed - indexed for MEDLINE]
18.
19.

New advances in the pathogenesis of ANCA-associated vasculitides.

Chen M, Kallenberg CG.

Clin Exp Rheumatol. 2009 Jan-Feb;27(1 Suppl 52):S108-14. Review.

PMID:
19646356
[PubMed - indexed for MEDLINE]
20.

Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA.

Schönermarck U, Lamprecht P, Csernok E, Gross WL.

Rheumatology (Oxford). 2001 Feb;40(2):178-84.

PMID:
11257154
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk